Viome PRO introduces blood test for pancreatic cancer

Viome Life Sciences’ clinical division, Viome PRO, has launched CancerDetect Pancreatic, according to Medical Device Network. The publication describes CancerDetect Pancreatic as a physician-ordered blood test designed to identify pancreatic ductal adenocarcinoma.

The product introduction centers on a blood-test format and a specific intended disease focus. Medical Device Network identified Viome PRO as the clinical division of Viome Life Sciences and named CancerDetect Pancreatic as the newly introduced test.

CancerDetect Pancreatic enters the physician-ordered category

Medical Device Network reported that CancerDetect Pancreatic is designed to identify pancreatic ductal adenocarcinoma. The report characterizes the offering as physician ordered, placing the launch within the physician-ordered blood-testing category.

For medical sales professionals working with diagnostic and laboratory stakeholders, the announcement provides a product-specific development to monitor. The published details identify the company division, test name, test format, and intended cancer focus.

The available report does not provide additional information on test use beyond its description as a physician-ordered blood test designed to identify pancreatic ductal adenocarcinoma. Medical Device Network’s coverage is focused on the launch of the product by Viome PRO.

Details reported by Medical Device Network

• Company division: Viome PRO, the clinical division of Viome Life Sciences
• Product: CancerDetect Pancreatic
• Format: Physician-ordered blood test
• Designed to identify: Pancreatic ductal adenocarcinoma
• Publisher: Medical Device Network

Launch takeaway

The event is the introduction of CancerDetect Pancreatic by Viome PRO. Medical Device Network reports that the test is designed to identify pancreatic ductal adenocarcinoma and is ordered by physicians.

Diagnostic and laboratory sales teams can use the reported product details to distinguish the launch clearly: CancerDetect Pancreatic is a blood test, it is physician ordered, and its stated purpose is identification of pancreatic ductal adenocarcinoma. The announcement also links the product to Viome PRO rather than referring only to Viome Life Sciences.